Logo image of GENC

GENCOR INDUSTRIES INC (GENC) Stock Fundamental Analysis

NYSEARCA:GENC - NYSE Arca - US3686781085 - Common Stock - Currency: USD

12.74  -0.21 (-1.62%)

After market: 12.74 0 (0%)

Fundamental Rating

6

Overall GENC gets a fundamental rating of 6 out of 10. We evaluated GENC against 129 industry peers in the Machinery industry. GENC has an excellent financial health rating, but there are some minor concerns on its profitability. GENC has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year GENC was profitable.
In the past year GENC had a positive cash flow from operations.
Of the past 5 years GENC 4 years were profitable.
Of the past 5 years GENC 4 years had a positive operating cash flow.
GENC Yearly Net Income VS EBIT VS OCF VS FCFGENC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.03%, GENC is in the better half of the industry, outperforming 72.80% of the companies in the same industry.
Looking at the Return On Equity, with a value of 8.33%, GENC is in line with its industry, outperforming 54.40% of the companies in the same industry.
GENC has a Return On Invested Capital (6.07%) which is in line with its industry peers.
GENC had an Average Return On Invested Capital over the past 3 years of 2.68%. This is significantly below the industry average of 11.00%.
The 3 year average ROIC (2.68%) for GENC is below the current ROIC(6.07%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.03%
ROE 8.33%
ROIC 6.07%
ROA(3y)3.51%
ROA(5y)3.98%
ROE(3y)3.77%
ROE(5y)4.26%
ROIC(3y)2.68%
ROIC(5y)3.07%
GENC Yearly ROA, ROE, ROICGENC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8

1.3 Margins

The Profit Margin of GENC (14.33%) is better than 87.20% of its industry peers.
GENC's Profit Margin has improved in the last couple of years.
GENC has a better Operating Margin (13.38%) than 68.00% of its industry peers.
GENC's Operating Margin has declined in the last couple of years.
GENC has a Gross Margin (28.80%) which is in line with its industry peers.
In the last couple of years the Gross Margin of GENC has remained more or less at the same level.
Industry RankSector Rank
OM 13.38%
PM (TTM) 14.33%
GM 28.8%
OM growth 3Y21.6%
OM growth 5Y-1.95%
PM growth 3Y25.24%
PM growth 5Y1.62%
GM growth 3Y4.03%
GM growth 5Y0.33%
GENC Yearly Profit, Operating, Gross MarginsGENC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GENC is destroying value.
GENC has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GENC has been increased compared to 5 years ago.
There is no outstanding debt for GENC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GENC Yearly Shares OutstandingGENC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
GENC Yearly Total Debt VS Total AssetsGENC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

GENC has an Altman-Z score of 19.25. This indicates that GENC is financially healthy and has little risk of bankruptcy at the moment.
GENC has a better Altman-Z score (19.25) than 96.80% of its industry peers.
GENC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 19.25
ROIC/WACC0.57
WACC10.6%
GENC Yearly LT Debt VS Equity VS FCFGENC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

GENC has a Current Ratio of 26.55. This indicates that GENC is financially healthy and has no problem in meeting its short term obligations.
GENC has a better Current ratio (26.55) than 99.20% of its industry peers.
GENC has a Quick Ratio of 17.52. This indicates that GENC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of GENC (17.52) is better than 98.40% of its industry peers.
Industry RankSector Rank
Current Ratio 26.55
Quick Ratio 17.52
GENC Yearly Current Assets VS Current LiabilitesGENC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

GENC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.65%, which is quite impressive.
Measured over the past 5 years, GENC shows a small growth in Earnings Per Share. The EPS has been growing by 3.07% on average per year.
The Revenue has been growing slightly by 5.44% in the past year.
The Revenue has been growing slightly by 1.28% on average over the past years.
EPS 1Y (TTM)34.65%
EPS 3Y38.09%
EPS 5Y3.07%
EPS Q2Q%-20.36%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y10.73%
Revenue growth 5Y1.28%
Sales Q2Q%-8.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GENC Yearly Revenue VS EstimatesGENC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
GENC Yearly EPS VS EstimatesGENC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2 2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.48, which indicates a very decent valuation of GENC.
GENC's Price/Earnings ratio is rather cheap when compared to the industry. GENC is cheaper than 88.00% of the companies in the same industry.
GENC is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.48
Fwd PE N/A
GENC Price Earnings VS Forward Price EarningsGENC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

GENC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GENC is cheaper than 96.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.27
EV/EBITDA -0.81
GENC Per share dataGENC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of GENC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.73
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GENC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENCOR INDUSTRIES INC

NYSEARCA:GENC (2/21/2025, 8:23:21 PM)

After market: 12.74 0 (0%)

12.74

-0.21 (-1.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-07 2025-02-07
Earnings (Next)05-08 2025-05-08
Inst Owners57.8%
Inst Owner Change-0.39%
Ins Owners17.22%
Ins Owner Change0%
Market Cap186.77M
Analysts85.71
Price TargetN/A
Short Float %0.45%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.48
Fwd PE N/A
P/S 1.65
P/FCF 8.27
P/OCF 7.67
P/B 0.96
P/tB 0.96
EV/EBITDA -0.81
EPS(TTM)1.11
EY8.71%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.54
FCFY12.09%
OCF(TTM)1.66
OCFY13.04%
SpS7.72
BVpS13.28
TBVpS13.28
PEG (NY)N/A
PEG (5Y)3.73
Profitability
Industry RankSector Rank
ROA 8.03%
ROE 8.33%
ROCE 7.77%
ROIC 6.07%
ROICexc 15.13%
ROICexgc 15.13%
OM 13.38%
PM (TTM) 14.33%
GM 28.8%
FCFM 19.96%
ROA(3y)3.51%
ROA(5y)3.98%
ROE(3y)3.77%
ROE(5y)4.26%
ROIC(3y)2.68%
ROIC(5y)3.07%
ROICexc(3y)6.31%
ROICexc(5y)9.51%
ROICexgc(3y)6.31%
ROICexgc(5y)9.51%
ROCE(3y)3.44%
ROCE(5y)3.93%
ROICexcg growth 3Y4.46%
ROICexcg growth 5Y-15.65%
ROICexc growth 3Y4.46%
ROICexc growth 5Y-15.65%
OM growth 3Y21.6%
OM growth 5Y-1.95%
PM growth 3Y25.24%
PM growth 5Y1.62%
GM growth 3Y4.03%
GM growth 5Y0.33%
F-Score7
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 65.7%
Cap/Sales 1.58%
Interest Coverage 250
Cash Conversion 136.42%
Profit Quality 139.25%
Current Ratio 26.55
Quick Ratio 17.52
Altman-Z 19.25
F-Score7
WACC10.6%
ROIC/WACC0.57
Cap/Depr(3y)119.83%
Cap/Depr(5y)117.66%
Cap/Sales(3y)3.37%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.65%
EPS 3Y38.09%
EPS 5Y3.07%
EPS Q2Q%-20.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.44%
Revenue growth 3Y10.73%
Revenue growth 5Y1.28%
Sales Q2Q%-8.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.41%
EBIT growth 3Y34.64%
EBIT growth 5Y-0.69%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y372.7%
FCF growth 3Y-33.36%
FCF growth 5YN/A
OCF growth 1Y513.95%
OCF growth 3Y-27.51%
OCF growth 5YN/A